Designed for professionals in the biopharma industry, our articles provide insights and analysis to support commercialization, logistics, field outsourcing and other business decisions.
Discover how a major biopharma brand paired CoverMyMeds solutions with effective formulary loss mitigation strategies to minimize therapy disruption in a competitive class.
At HLTH USA 2025, Kevin Kettler, President of CoverMyMeds, joined fellow healthcare leaders on the panel session, “Patients Know First,” to explore how the industry can better align with the evolving expectations to ensure patients remain at the center of all decisions.
Biopharma is at a crossroads. With policy shifts reshaping economics, Pharmacy Benefit Manager dynamics restricting access and patients demanding consumer-grade experiences, the old playbook for patient access is under strain.
In this podcast moderated live at Asembia 2025, CoverMyMeds and Industry experts discuss the current state of prescription access challenges associated with prior authorizations for GLP-1 medications.
Discover how a major biopharma brand paired CoverMyMeds solutions with effective formulary loss mitigation strategies to minimize therapy disruption in a competitive class.
At HLTH USA 2025, Kevin Kettler, President of CoverMyMeds, joined fellow healthcare leaders on the panel session, “Patients Know First,” to explore how the industry can better align with the evolving expectations to ensure patients remain at the center of all decisions.
Biopharma is at a crossroads. With policy shifts reshaping economics, Pharmacy Benefit Manager dynamics restricting access and patients demanding consumer-grade experiences, the old playbook for patient access is under strain.
In this podcast moderated live at Asembia 2025, CoverMyMeds and Industry experts discuss the current state of prescription access challenges associated with prior authorizations for GLP-1 medications.
